There’s always something new and exciting going on at xCell Strategic Consulting. Check out our announcements below for the very latest.


  • Bigelow Predicts 2017 to be a Break-Out Year for CDMOs

    December 2016

    Peter Bigelow, President, predicts that the CDMO industry will continue to consolidate and mature, which will drive pharmaceutical companies to be receptive to partnering.  He forecasts that 2017 will be a break out year for the types of partnering contracts that are signed.  Read his industry insights in the December 19, 2016 issue of Outsourced Pharma.

  • Bigelow Presents at CPhI Conference

    October 2016

    Peter Bigelow, President, presented "Assessing Risk and Building Supply Chain Reliability or The 8 Habits of World Class Supply Chains" at the 2016 CPhI Conference held in Barcelona, Spain, October 4 - 6.  Principals Ray Sison and Balu Balasubramanian also attended the industry event, which brings together more than 36,000 pharma industry professionals from over 150 countries.

  • Principals Play Integral Role on ISPE Drug Shortage Prevention Steering Committee

    November 2015

    xCell Strategic Consulting members are key players on the ISPE Drug Shortage Steering Committee and were document review contributors to the comprehensive tool for assessment of preparedness for preventing drug shortages of important medicines recently released by the organization’s Drug Shortage Prevention Task Force.  This tool builds on the ISPE Drug Shortage Prevention Plan and has had input from many members of the ISPE and regulators worldwide.  The document is free to ISPE members.

  • Executives Moderate Sessions at Outsourced Pharma West

    November 2015

    Peter Bigelow, President, and Balu Balsubramanian, Principal, of xCell Strategic Consulting served as panelists at the second annual Outsourced Pharma West Conference held in San Francisco. This meeting brought together many drug development companies with CROs, CDMOs and industry experts to discuss partnering best practices and industry trends.  Bigelow moderated two panels – “Project Management and Your Outsourcing Partner” and “Strategies for Getting to Your First GMP Batch.”  Balasubramanian served as a panelist on a session titled, “Getting Real: How Much is Outsourcing My Project Going to Cost.”

  • President to Serve as PBOA Chairman of the Board of Trustees

    October 29, 2014

    Peter Bigelow, President of xCell Strategic Consulting, has been elected to serve a two year term as Chairman of the Board of Trustees of the Pharma & Biopharma Outsourcing Association (PBOA).


    The PBOA is a non-profit trade association that will help advance the regulatory, legislative and business interests of Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations (CMOs/CDMOs).  Members represent large and small molecules, APIs to finished dosage forms, and cover the gamut from single-site to multi-national companies.


    In his role as Chairman of the Board of Trustees, Peter will work with the Board and with PBOA President Gil Roth to develop the PBOA’s agenda, represent the association in its regulatory, legislative and business mission, and serve as liaison between the Board and member companies.

  • Executives Attend Ground Breaking Event in United Arab Emirates

    September 17, 2014
    Life Pharma, FZE, a privately held pharmaceutical company based in the United Arab Emirates, breaks ground on a new oncology product manufacturing facility in Kizad, U.A.E. The groundbreaking ceremony represents an exciting milestone for the growth of Life Pharma. Peter Bigelow and Balu Balusubmaranian serve on the Board of Directors of Life Pharma, FZE and as advisors to the company. They attended the groundbreaking ceremony along with a number of Life Pharma executives and United Arab Emirates government officials.

  • Principal Honored at Daiichi Sankyo in Bethlehem, PA

    August 13, 2014
    Jim Robinson, Principal, and Peter Bigelow, President, xCell Strategic Consulting, participated in a ceremony to welcome Hal Lewis as new Plant Director for Daiichi Sanyo Bethlehem Operations.  Jim Robinson was honored for his service as Interim Plant Director.  A celebration was held to honor Jim at an all-hands meeting that included employees and executives of Daiichi Sankyo Bethlehem.


  • Executives Conduct Webinar

    July 22, 2014
    Peter Bigelow, CEO, and Craig Seyfried, Principal, xCell Strategic Consulting, conducted a Webinar sponsored by the Life Science Training Institute titled: The Seven Characteristics of World Class Supply Chains.


  • xCell Participates in Interphex 2018

    xCell Strategic Consulting principals will attend 
    Interphex 2018, April 17 – 19. 2018, at the Javits Center in New York City.  The conference is a pharmaceutical, biotechnology and device development and manufacturing event that brings together over 11,000 global industry professionals and 650 suppliers. Industry executives will participate in technical conferences, exhibits, demonstrations and networking events. 

    New for 2018 are exhibits focused on contract development and manufacturing and design to meet the needs of industry professionals looking for access to leading Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs).

    Click for More Information

  • DCAT Week, March 19 – 22, 2017

    xCell Strategic Consulting principals will attend DCAT Week, March 19 – 22, 2017, in New York City.  The event is sponsored by the Drug Chemical and Associated Technologies Association (DCAT), a not-for-profit organization that powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing.  Held annually, executives from pharmaceutical and biopharmaceutical companies, as well as CDMOs, CMOs and other suppliers are expected to attend.

    Click for More Information